In line, a meta-analysis including 49 studies confirms that n-3 PUFA decreases the levels of IL-6 and CRP in middle-aged and older adults [124], thereby reducing the components of inflammageing, which contributes to sarcopenia. The gene discussed is CRP; the disease is sarcopenia.